Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries.

[2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.

The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.

[3] In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design.

The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.